Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
New California Habit Drive-Thru Restaurant to Open Doors on December 17Holding Pre-Opening VIP Event on December 16 IRVINE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Habit, the California-based...
Read More -
New Jersey Habit Restaurant to Open Doors on December 17Hold Pre-Opening VIP Events on December 13, 15-16 IRVINE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Habit, the California-based restaurant...
Read More
-
CAMBRIDGE, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to...
-
CLEVELAND, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, has signed a definitive agreement to sell its CertaSite®...
-
New California Habit Drive-Thru Restaurant to Open Doors on December 17Holding Pre-Opening VIP Event on December 16 IRVINE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Habit, the California-based...
-
LONDON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ:WTW), a leading global advisory, broking and solutions company, and Cushon, a workplace pensions, savings and financial wellbeing company, are...
-
Xtract One Secures SmartGateway Contract with Leading Nationwide Healthcare Provider to Bolster Safety at Clinics Across the Midwest
-
Kfar Saba, Israel, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The aircraft of Ukrainian President Volodymyr Zelensky received an unusual escort, thrusting into the spotlight the major security challenge of...
-
Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to monomer and plaque ProMIS on track to complete enrollment in PRECISE-AD trial...
-
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case...
-
BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS®) Phase 3 study of Bria-IMT™ plus immune check point inhibitor (CPI) continues to support...
-
The Boston Club and Bentley University's annual census shows the slowest progress in MA for women in corporate leadership since 2017.